A side effect is a change caused by something you did. Documenting one takes a group of people doing the thing, a comparison group, and a measurement. For deliberate semen retention, none of that exists. Search the medical literature for the term and you get work on urinary retention, on evolutionary "mate retention" behaviour, and clinical anthropology on Dhat syndrome, a South Asian idiom of distress centred on semen loss, which is a different subject in a different population. There is no prospective study of men abstaining on purpose, with a defined protocol, measured endpoints and a comparison group.
So everything below is borrowed from adjacent research: mostly studies of ejaculation frequency in men who were not trying to retain, measured over days rather than weeks, often in fertility clinic populations. That limitation applies in both directions, and it is why the most common error in this topic, made by promoters and debunkers alike, is treating a measured change as a demonstrated harm. It is also worth saying at the top that where the borrowed evidence points anywhere at all, it does not always point where practitioners expect. The largest prospective dataset in this area associates more frequent ejaculation with lower prostate cancer incidence. That section is below, in full.
Blue balls: a real sensation with almost no literature
Ache in the testicles and lower abdomen after prolonged arousal without ejaculation is widely reported. The clinical evidence for it is close to nonexistent. The single most cited medical source is a one page case report of one patient, published in Pediatrics in 2000. A 2024 commentary in the Journal of Sexual Medicine, written as a comment on that same case report, asks openly whether the condition exists and notes it has essentially no coverage in sexual medicine.
A 2025 historical review in Sexual Medicine Reviews found that scrotal pain of this kind was discussed extensively between the 1820s and the 1920s under many competing diagnostic labels, across Latin, French, German, Dutch, Italian and English sources, and that those descriptions were shaped by contemporary arguments both against masturbation and against overly rigid continence. The same complaint has been mobilised on both sides of this argument for two centuries. The mechanism usually offered, sustained vasocongestion of the epididymis and spermatic cord raising local pressure, has never been measured in a human. There is no prevalence study, no imaging study, no pressure measurement, no controlled description of onset or resolution.
The term epididymal hypertension implies a measured pressure that has never been recorded.
Blue balls, or epididymal hypertension, is a documented medical condition caused by not ejaculating.
Many men report the sensation and it is plausible on general vascular grounds. The clinical citation chain rests on one case report of one patient (Pediatrics, 2000), a 2024 commentary treating its existence as unresolved, and a historical review of nineteenth century terminology. No prevalence, imaging or pressure data exist.
The pelvic floor question is genuinely open
Neither direction has been studied. There is no trial, cohort or case series taking ejaculatory abstinence as the exposure and chronic prostatitis or chronic pelvic pain syndrome as the outcome. What exists is adjacent and does not answer the question.
Sexual and ejaculatory dysfunction is very common in men who already have CP/CPPS: in a clinic series of 296 patients, 214 of them, or 72.3 percent, reported erectile difficulty, ejaculatory difficulty, or both, and those reporting both had worse symptom scores and quality of life. Painful ejaculation has a reported incidence somewhere between 1 and 9.7 percent, associated with benign prostatic hyperplasia, CP/CPPS, ejaculatory duct obstruction, prostate surgery and some antidepressants. Pelvic floor physical therapy does show benefit for pelvic floor hypertonicity including CP/CPPS, but that evidence base is 10 studies of which only 4 are randomised, six rated low quality by the reviewers, and none of them examined abstinence or ejaculatory frequency at all.
Because pelvic pain itself changes how often a man ejaculates, any observed link between frequency and pain could run in either direction. "Prostatic congestion" is a nineteenth century inference that modern urology has not tested, for or against.
Retention causes prostate congestion, pelvic floor tension and chronic pelvic pain. Or the reverse: it relieves them.
No study has examined abstinence as an exposure with pelvic pain as an outcome. The adjacent evidence establishes co-occurrence between CP/CPPS and sexual dysfunction (214 of 296 men, 72.3 percent) and says nothing about direction. Anyone claiming a settled answer here, either way, is going beyond the literature.
What happens to semen across days of abstinence
This is the one area with real data, and the parameters move in opposite directions. In a retrospective analysis of 9,489 samples from 6,008 patients, mean volume rose from 2.3 mL at 0 to 1 days of abstinence to 3.9 mL at 8 to 14 days. Motility and morphology went the other way: peak motility in oligozoospermic samples occurred after one day, peak normal morphology in mildly to moderately oligozoospermic samples occurred between 0 and 2 days, and normozoospermic samples showed a significant fall in motility and normal morphology, to 33.1 percent and 7.0 percent, by days 11 to 14. Those authors recommend not exceeding 10 days.
A 2024 meta-analysis of 13 studies covering 2,315 men found the same pattern: longer abstinence gave higher concentration and volume but lower progressive motility. More semen, containing more sperm, that swim less well. Whether that counts as better depends entirely on what you are measuring for, and nobody has measured it for anything retention practitioners actually care about. The volume increase is the easiest change to notice, which is why it gets read as proof of improved quality, and it is close to the least informative parameter about sperm function.
Describing a change is not the same as documenting a harm.
Holding it in for weeks builds up better, stronger, more potent semen.
Volume and concentration rise; progressive motility falls. In 9,489 samples volume went from 2.3 mL to 3.9 mL between days 0-1 and days 8-14, while normozoospermic motility fell to 33.1 percent by days 11-14. A meta-analysis of 13 studies and 2,315 men agrees on direction. Fertility clinic populations, measured across days, not weeks.
Longer abstinence is associated with higher sperm DNA fragmentation on laboratory assays.
The 2024 meta-analysis (13 studies, 2,315 men) found a pooled mean difference of 3.46 and a meta-regression relating days of abstinence to fragmentation linearly, slope 0.65, p=0.044. Assays differ between studies and the clinical meaning of a given fragmentation percentage is contested within andrology. This is a laboratory measurement, not a demonstrated harm, and the fitted range was days, so extrapolating it to weeks is unwarranted.
A separate 2022 systematic review of 19 studies found that in men with already abnormal parameters, a second ejaculate collected within four hours of the first had significantly lower DNA fragmentation. Only 5 of the 19 studies measured fragmentation at all, and the improvement was specific to men whose parameters were already abnormal. Both camps misuse this finding: anti-retention writing quotes it as evidence of damage, pro-retention writing ignores it.
The zinc argument, settled with two numbers
You do not need a trial for this one. Total zinc per ejaculate, measured by flame atomic absorption spectrometry in 152 men, averaged 336 micrograms in samples of normal viscosity and 305 micrograms in samples of normal viability, with the subgroup values running roughly 220 to 440 micrograms. The recommended dietary allowance for adult men is 11 milligrams per day and the tolerable upper intake level is 40 milligrams per day.
So one ejaculate holds about 0.3 mg of zinc, roughly 3 percent of a single day's recommended intake. Ejaculating every day for a month totals around 9 mg, which is less than one day's RDA. The figure that circulates in retention communities, usually 5 mg or 9 mg per ejaculate, appears to come from confusing a concentration with a total, or from reading a per litre value as a per ejaculate value. The measured total is about one thirtieth of a day's requirement.
The first two bars are totals of zinc contained in ejaculate; the second two are daily intake standards. The per ejaculate figure is the 336 microgram mean measured in normal viscosity samples (Dissanayake 2010, 152 men). RDA and upper limit from the Institute of Medicine dietary reference intakes.
See the numbers
| One ejaculate | 0.34mg of zinc |
|---|---|
| Daily ejaculation for 30 days | 9mg of zinc |
| Daily RDA, adult men | 11mg of zinc |
| Tolerable upper intake, per day | 40mg of zinc |
Zinc in seminal plasma does have real functions and is measured clinically as a marker of prostate secretory function. But a study of 115 infertile couples found no significant correlation between total zinc per ejaculate, or seminal zinc concentration, and any measured sperm characteristic, which undercuts the secondary assumption that seminal zinc tracks semen quality in any simple way.
Each ejaculation costs you a significant amount of zinc, so retention preserves zinc status.
Measured total zinc per ejaculate is roughly 0.22 to 0.44 mg (n=152), against an RDA of 11 mg per day and an upper limit of 40 mg per day. The quantity at stake sits far inside ordinary dietary variation. The popular figure is off by roughly a factor of thirty.
The finding that runs against the practice
The largest prospective dataset in this area points the opposite way from the prostate claim, and it should be stated straight. In the Health Professionals Follow-up Study, 31,925 men reported average monthly ejaculation frequency in 1992 and were followed to 2010. Across 480,831 person-years there were 3,839 prostate cancers. Men reporting 21 or more ejaculations per month had lower incidence than men reporting 4 to 7: hazard ratio 0.81 for frequency at ages 20-29 and 0.78 at ages 40-49, both with p below 0.0001 for trend. A 2025 meta-analysis of 29 studies and 315,193 participants found a pooled odds ratio of 0.83 for higher ejaculation frequency.
The objections that actually hold
Forums often dismiss the cohort finding as an artefact of PSA screening. It is not: the authors tested that objection directly, showing screening and biopsy rates were similar across frequency categories and that the association held within the screened subgroup. The honest criticisms are different ones. The exposure is self-reported recall of frequency decades earlier, in a cohort of US male health professionals. The associations were concentrated in low risk, screen detected disease. The earlier analysis of the same cohort found no statistically significant association with advanced prostate cancer, but it had only 147 advanced cases, so that null is underpowered rather than a demonstrated absence. A UK case-control study of 431 cases and 409 controls diagnosed at 60 or younger found the opposite direction in early adulthood, with sexual activity in the twenties and masturbation in the twenties and thirties associated with higher risk. The 2025 meta-analysis is not independent replication, since it pools studies including the cohort analyses themselves, and it found masturbation frequency specifically was not significantly associated with risk, which sits awkwardly beside the ejaculation result. A 2024 narrative review of eleven studies concluded that no consensus exists.
None of that rescues the claim. Nobody has measured a retention group, and nobody has shown that ejaculation frequency changes the odds of dying of prostate cancer as opposed to being diagnosed with it. What can be said is that the largest prospective observation in this area is inconsistent with the idea that holding it in benefits the prostate.
Retaining semen is good for your prostate.
The largest prospective cohort (31,925 men, 480,831 person-years, 3,839 cases) associates 21 or more ejaculations per month with lower prostate cancer incidence, HR 0.81 and 0.78, and a 2025 meta-analysis of 315,193 participants pools an OR of 0.83 while partly containing that same cohort. Observational, concentrated in low risk screen detected disease, and no retention group has ever been studied. It is still evidence pointing the other way.
The markers practitioners track: wet dreams and morning erections
A 2026 systematic scoping review covering 157 sources found that the evidence did not support the historical view of nocturnal emissions as compensatory release under conditions of low sexual outlet, and that emissions occurred both with and without erotic dreams. Emissions are close to universal, reported by 70 to 90 percent of men, typically first occurring at 13-14 years, and the reviewers described frequency data as scarce and inconsistent. One small cross-sectional study of 113 religious male teenagers found that having emissions was unrelated to time since last masturbation, p=0.479, which is weak evidence from a small sample in a setting where reporting bias about masturbation is likely.
So the hydraulic model, in which pressure accumulates and eventually finds an outlet, has not been demonstrated. Note the shape of that conclusion: it rests mostly on an absence of supporting evidence, not on a strong demonstration of the opposite.
Wet dreams are the body's pressure release valve: retain long enough and you will have one.
A 2026 scoping review of 157 sources found no support for the compensatory release model, and one small study (n=113) found no relationship between emissions and time since last masturbation, p=0.479. Emission frequency has not been shown to track abstinence duration in either direction, and the reviewers called for prospective research.
Erections, and the marker that turned out not to predict anything
No study has measured erectile function in men practising deliberate retention. The only prospective population data on the adjacent question sit in a Finnish five year follow up of 989 men aged 55 to 75 who were free of erectile dysfunction at baseline. Men reporting intercourse less than once per week had an incidence of moderate or complete erectile dysfunction of 79 per 1000 person-years versus 33 per 1000 for those reporting once per week, adjusted incidence rate ratio 2.2. That study measured intercourse rather than ejaculation, in men thirty years older than the typical practitioner, and reverse causation is its central weakness: early subclinical difficulty reduces intercourse before it gets reported as dysfunction. The same study found no relationship between morning erections and later erectile dysfunction, which is worth knowing, because morning erections are among the most tracked self-reported markers in these communities.
Retaining too long will wreck your erections.
Nothing has been measured in men practising retention. The nearest prospective data (989 men aged 55-75) associate infrequent intercourse with later erectile dysfunction, IRR 2.2, in a design that cannot rule out the difficulty causing the infrequency, and that measures intercourse rather than ejaculation. Persistent erectile difficulty is a reason to see a doctor, not to reason from this study.
Mood, and what self-report can carry
Nothing has measured mood during deliberate semen retention. The nearest randomised evidence concerns pornography rather than semen: 176 undergraduates were randomised to seven days of abstinence or continuing as usual, with daily surveys, and the pre-registered withdrawal hypothesis was not supported, with no significant group effects on craving, positive affect, negative affect or withdrawal symptoms. That sample was 64.2 percent female, Malaysian, and self-reporting compliance, with 45.35 percent of the abstinence group lapsing inside the week. A seven day study in a majority female student sample cannot settle what happens to a man at week six, in either direction.
Distress in this territory is real and common. A nationally representative US survey of 2,325 adults found 8.6 percent overall, and 10.3 percent of men, reported clinically relevant distress or impairment around difficulty controlling sexual feelings, urges and behaviours. That measured distress, not causes.
The most robust finding in the psychology of this area is also the least quoted in practitioner spaces. A systematic review and meta-analysis of moral incongruence, the experience of behaving against your own beliefs, found it associated with greater distress about one's use, greater general psychological distress, more reported problems and higher perceived addiction, independent of how much a man actually used. This does not make the distress fake or unimportant. It does mean a questionnaire asking whether your use feels out of control is partly measuring self-judgement, so comparing your answer to another man's tells you very little. The ICD-11 makes the same distinction from the clinical side: compulsive sexual behaviour disorder is coded 6C72 under impulse control disorders and deliberately not under addictive behaviours, and its criteria state that distress arising entirely from moral judgement of one's own impulses is not sufficient for the diagnosis.
The flatline is withdrawal, and withdrawal proves it was an addiction.
The one randomised abstinence study (176 undergraduates, seven days, 64.2 percent female, pornography rather than semen) found no group differences on craving or affect, and nearly half the abstinence arm lapsed within the week. That is a weak test of a claim about men abstaining for weeks, so the claim is unevidenced rather than disproved. A subjective flatline is equally consistent with expectancy and with normal variation noticed only because someone is watching for it.
Streak framing has no evidence either way
On streak focus specifically there is no evidence at all, and that deserves saying rather than filling with speculation. What is documented is adjacent: a meta-analysis of 138 randomised studies with 19,951 participants found that prompting people to monitor progress toward a goal reliably improved performance and goal attainment, with larger effects when progress was recorded or made public. That says monitoring is an active ingredient. It says nothing about whether an all or nothing counter is good or bad for anyone, and it cuts both ways for anyone tracking a practice: a man logging daily is running two things at once, and the log cannot separate them.
Relapsing sets you back to zero and undoes your progress.
Nothing has measured the psychological effects of streak framing in this population, and nothing has measured what a relapse does to any bodily or psychological outcome. Goal monitoring itself has good evidence behind it (138 studies, N=19,951), which makes tracking both useful and a confound. Whether a resettable counter helps or harms has not been studied, and neither confident answer is earned.
One more finding belongs here, stated without sneering. A survey of 1,063 respondents, recruited through a general Reddit thread rather than an abstinence community, found motivation to abstain was associated mainly with attitudinal factors, particularly the belief that masturbation is unhealthy, along with conservatism, religiosity and lower trust in science, rather than with behavioural markers of compulsivity. That describes who is drawn to the practice. It says nothing about what the practice does, and it is not a reason to dismiss anyone's experience.
When it is a doctor, not a forum
Some of what gets logged as a side effect belongs in a clinic. Take these to a doctor rather than a thread:
- Low mood that persists for weeks, and any thought of harming yourself. In a nationally representative US survey of 2,325 adults, 10.3 percent of men reported clinically relevant distress or impairment around controlling sexual feelings and behaviour, so this is not a rare thing to bring to a clinician.
- Testicular, scrotal or pelvic pain that does not settle. Sudden, severe testicular pain needs urgent medical assessment rather than a wait.
- Pain on ejaculation, with a reported incidence of 1 to 9.7 percent and a differential that includes benign prostatic hyperplasia, CP/CPPS, ejaculatory duct obstruction, prostate surgery and some antidepressants. A forum cannot work through that list.
- Erectile difficulty that persists, which is worth a medical assessment regardless of what you are or are not doing sexually.
- Blood in semen or urine, or any change in the urinary stream.
None of this is an argument against the practice. It is an argument against reading your own symptoms through a framework that decided in advance what they mean.